GLOBAL TOP 10 BIOTECHNOLOGY COMPANIES ? INDUSTRY, FINANCIAL AND SWOT ANALYSIS
Introduction
This inform analyzes a tellurian biotechnology marketplace in conditions of marketplace distance (reflects revenues of companies inside of this attention from product sales, chartering fees, royalties as well as investigate funding), pass drivers as well as resistors, trends as well as rival positioning. It includes profiles of a tip 10 companies in a attention along with 5-year monetary research as well as in-depth SWOT analysis.
Scope
*Performance of a tellurian biotechnology marketplace upon a basement of sales, volume as well as particular expansion patterns over a past 5 years
*Obtain detailed profiles of a tip 10 heading players together with vital initiatives undertaken in a final twelve months
*Analysis of a Strengths, Weaknesses, Opportunities as well as Threats of a tip 10 biotechnology companies along with commercial operation general outlook as well as financials
*Benchmark a opening of a tip 10 players for a past 5 years; includes income comparison, profitability analysis, industry-specific ratios
Highlights
The tellurian biotechnology marketplace grew by 10.6% in 2007 to strech a worth of $171,803 million.
In 2012, a tellurian biotechnology marketplace is foresee to have a worth of $275,757 million, an enlarge of 60.5% over 2007.
In worth terms, a medical/healthcare shred generated 69.4% of a tellurian biotechnology marketplace value.
Reasons to Purchase
*Save time, income as well as resources upon analyzing a tip 10 biotechnology companies regulating this report
*Analyze a tellurian biotechnology marketplace with pass attention metrics together with marketplace value, marketplace volume, as well as expansion forecasts
*Assess a energy of foe formed upon a 5-forces indication together with grade of rivalry, substitutes, brand new entrants, customer energy as well as retailer power
Table of Contents :
FIGURES 3
Tables 4
Executive Summary 5
Industry research 5
Industry clarification 5
Research highlights 5
Top 10 companies landscape 6
Top 10 companies landscape 6
Market Value 7
Market Forecast 8
Market Segmentation-Product 9
Market Segmentation-Geographic 10
Five Forces Analysis 11
Summary 11
Buyer energy 12
Supplier energy 13
New entrants 14
Substitutes 15
Rivalry 16
Top 10 Companies Landscape 17
Top 10 Companies Landscape 17
Amgen 18
Genentech 18
Gilead Sciences 19
UCB 19
Genzyme 19
Biogen Idec 19
CSL 19
Celgene 19
Cephalon 20
Actelion 20
Revenue research 21
Financial opening research 23
Operating distinction research 24
Net distinction research 25
Ratio research 26
Company Reports 28
Amgen 28
Company general outlook 28
Business outline 28
SWOT research 29
Strengths 29
Weaknesses 29
Opportunities 30
Threats 31
Recent developments 32
Genentech 33
Company general outlook 33
Business outline 33
SWOT research 34
Strengths 34
Weaknesses 35
Opportunities 36
Threats 37
Recent developments 37
Gilead Sciences 38
Company general outlook 38
Business outline 38
SWOT research 39
Strengths 39
Weaknesses 39
Opportunities 39
Threats 40
Recent developments 41
UCB 42
Company general outlook 42
Business outline 42
SWOT research 43
Strengths 43
Weaknesses 44
Opportunities 44
Threats 45
Recent developments 45
Genzyme 47
Company general outlook 47
Business outline 47
SWOT research 48
Strengths 48
Weaknesses 49
Opportunities 49
Threats 50
Recent developments 50
Biogen Idec 52
Company general outlook 52
Business outline 52
SWOT research 53
Strengths 53
Weaknesses 53
Opportunities 54
Threats 54
Recent developments 55
CSL 56
Company general outlook 56
Business outline 56
SWOT research 57
Strengths 57
Weaknesses 58
Opportunities 58
Threats 59
Recent developments 60
Celgene 61
Company general outlook 61
Business outline 61
SWOT research 61
Strengths 61
Weaknesses 62
Opportunities 62
Threats 63
Recent developments 64
Cephalon 65
Company general outlook 65
Business outline 65
SWOT research 66
Strengths 66
Weaknesses 66
Opportunities 66
Threats 67
Recent developments 68
Actelion 69
Company general outlook 69
Business outline 69
SWOT research 70
Strengths 70
Weaknesses 70
Opportunities 71
Threats 72
Recent developments 72
Financial Analysis 73
Amgen 73
Genentech 76
Gilead Sciences 79
UCB 82
Genzyme 85
Biogen Idec 88
CSL 91
Celgene 94
Cephalon 97
Actelion 100
Appendix 103
For some-more information, greatfully revisit :